An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease<FNR></FNR><FN>An earlier version of this paper was presented at the 18 March, 2000 meeting of the FDA Psychopharmacological Drugs Advisory Committee. </FN>

Discusses information on a proposal for the classification of neuropsychiatric disturbance in patients with Alzheimer&#39;s disease. Method of empirical categorization of disturbances; Comparison of the frequency of individual neuropsychiatric symptoms with or without dementia based on the Cache County study of memory and aging in Utah; List of the proposed diagnostic criteria for Alzheimer&#39;s disease-associated neuropsychiatric disturbance; Relevance of the proposed criteria to clinical research and practice.